Design and synthesis of novel and potent allosteric HIV-1 integrase inhibitors with a spirocyclic moiety

被引:2
作者
Adachi, Kaoru [1 ]
Manabe, Tomoyuki [2 ]
Yamasaki, Takayuki [3 ]
Suma, Akira [2 ]
Orita, Takuya [1 ]
Furuzono, Tomoko [1 ]
Adachi, Tsuyoshi [1 ]
Ohata, Yoshitsugu [4 ]
Akiyama, Yoshiyuki [5 ]
Miyazaki, Susumu [1 ]
机构
[1] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Chem Res Labs, 1-1,Murasaki Cho, Takatsuki, Osaka 5691125, Japan
[2] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Innovat Implementat Labs, 1-1,Murasaki Cho, Takatsuki, Osaka 5691125, Japan
[3] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Dept Res Planning, Preclin, 1-1,Murasaki Cho, Takatsuki, Osaka 5691125, Japan
[4] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Biol Pharmacol Res Labs, 1-1,Murasaki Cho, Takatsuki, Osaka 5691125, Japan
[5] Japan Tobacco Inc, Cent Pharmaceut Res Inst, DMPK Res Labs, 1-1,Murasaki Cho, Takatsuki, Osaka 5691125, Japan
关键词
HIV-1; integrase; Allosteric inhibitor; LEDGF/p75; LEDGF/P75; MULTIMERIZATION; REPLICATION; PREVENTION; DISCOVERY; SITE;
D O I
10.1016/j.bmcl.2024.129864
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report herein the design and discovery of novel allosteric HIV-1 integrase inhibitors. Our design concept utilized the spirocyclic moiety to restrain the flexibility of the conformation of the lipophilic part of the inhibitor. Compound 5 showed antiviral activity by binding to the nuclear lens epithelium-derived growth factor (LEDGF/ p75) binding site of HIV-1 integrase (IN). The introduction of a lipophilic amide substituent into the central benzene ring resulted in a significant increase in antiviral activity against HIV-1 WT X-ray crystallography of compound 15 in complex with the integrase revealed the presence of a hydrogen bond between the oxygen atom of the amide of compound 15 and the hydroxyl group of the T125 side chain. Chiral compound 17 showed high antiviral activity, good bioavailability, and low clearance in rats.
引用
收藏
页数:6
相关论文
共 30 条
[1]  
[Anonymous], 2014, HIV/AIDS fact sheet
[2]   Prospects for Treatment of Latent HIV [J].
Barton, K. M. ;
Burch, B. D. ;
Soriano-Sarabia, N. ;
Margolis, D. M. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (01) :46-56
[3]   Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration [J].
Bonnard, Damien ;
Le Rouzic, Erwann ;
Eiler, Sylvia ;
Amadori, Celine ;
Orlov, Igor ;
Bruneau, Jean-Michel ;
Brias, Julie ;
Barbion, Julien ;
Chevreuil, Francis ;
Spehner, Daniele ;
Chasset, Sophie ;
Ledoussal, Benoit ;
Moreau, Francois ;
Saib, Ali ;
Klaholz, Bruno P. ;
Emiliani, Stephane ;
Ruff, Marc ;
Zamborlini, Alessia ;
Benarous, Richard .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (16) :6172-6186
[4]   Identification of the LEDGF/p75 binding site in HIV-1 integrase [J].
Busschots, Katrien ;
Voet, Arnout ;
De Maeyer, Marc ;
Rain, Jean-Christophe ;
Emiliani, Stephane ;
Benarous, Richard ;
Desender, Linda ;
Debyser, Zeger ;
Christ, Frauke .
JOURNAL OF MOLECULAR BIOLOGY, 2007, 365 (05) :1480-1492
[5]   Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication [J].
Christ, Frauke ;
Voet, Arnout ;
Marchand, Arnaud ;
Nicolet, Stefan ;
Desimmie, Belete A. ;
Marchand, Damien ;
Bardiot, Dorothee ;
Van der Veken, Nam Joo ;
Van Remoortel, Barbara ;
Strelkov, Sergei V. ;
De Maeyer, Marc ;
Chaltin, Patrick ;
Debyser, Zeger .
NATURE CHEMICAL BIOLOGY, 2010, 6 (06) :442-448
[6]   A role for LEDGF/p75 in targeting HIV DNA integration [J].
Ciuffi, A ;
Llano, M ;
Poeschla, E ;
Hoffmann, C ;
Leipzig, J ;
Shinn, P ;
Ecker, JR ;
Bushman, F .
NATURE MEDICINE, 2005, 11 (12) :1287-1289
[7]   Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication [J].
De Rijck, Jan ;
Vandekerckhove, Linos ;
Gijsbers, Rik ;
Hombrouck, Anneleen ;
Hendrix, Jelle ;
Vercammen, Jo ;
Engelborghs, Yves ;
Christ, Frauke ;
Debyser, Zeger .
JOURNAL OF VIROLOGY, 2006, 80 (23) :11498-11509
[8]   LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions [J].
Desimmie, Belete Ayele ;
Schrijvers, Rik ;
Demeulemeester, Jonas ;
Borrenberghs, Doortje ;
Weydert, Caroline ;
Thys, Wannes ;
Vets, Sofie ;
Van Remoortel, Barbara ;
Hofkens, Johan ;
De Rijck, Jan ;
Hendrix, Jelle ;
Bannert, Norbert ;
Gijsbers, Rik ;
Christ, Frauke ;
Debyser, Zeger .
RETROVIROLOGY, 2013, 10
[9]   Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication [J].
Emiliani, S ;
Mousnier, A ;
Busschots, K ;
Maroun, M ;
Van Maele, B ;
Tempé, D ;
Vandekerckhove, L ;
Moisant, F ;
Ben-Slama, L ;
Witvrouw, M ;
Christ, F ;
Rain, JC ;
Dargemont, C ;
Debyser, Z ;
Benarous, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (27) :25517-25523
[10]   Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1 [J].
Fader, Lee D. ;
Malenfant, Eric ;
Parisien, Mathieu ;
Carson, Rebekah ;
Bilodeau, Francois ;
Landry, Serge ;
Pesant, Marc ;
Brochu, Christian ;
Morin, Sebastien ;
Chabot, Catherine ;
Halmos, Ted ;
Bousquet, Yves ;
Bailey, Murray D. ;
Kawai, Stephen H. ;
Coulombe, Rene ;
LaPlante, Steven ;
Jakalian, Araz ;
Bhardwaj, Punit K. ;
Wernic, Dominik ;
Schroeder, Patricia ;
Amad, Ma'an ;
Edwards, Paul ;
Garneau, Michel ;
Duan, Jianmin ;
Cordingley, Michael ;
Bethell, Richard ;
Mason, Stephen W. ;
Boes, Michael ;
Bonneau, Pierre ;
Poupart, Marc-Andre ;
Faucher, Anne-Marie ;
Simoneau, Bruno ;
Fenwick, Craig ;
Yoakim, Christiane ;
Tsantrizos, Youla .
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (04) :422-427